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1. Introduction
Individuals in the post-operative period immediately
after liver transplantation (LxT) may experience a decline
in their physical capacity (PC), life quality (LQ), and respi-
ratory capacity (RC). These complications may be due to
reduced muscle strength, weakness, malnutrition, and fa-
tigue as the consequences of surgical procedures and hos-
pitalization (1).
In the presence of a new organ, the function tends to
return to normal, but the PC, RC, and LQ seem to act dif-
ferently. The pulmonary function and respiratory muscle
strength tend to match the expected values by one month
after LxT (2). The LQ results, measured by short form-36
questionnaire (SF-36), are different because life capacity is
dynamic and recovers quickly in the first six months after
surgery. This may be influenced by many factors such as co-
morbidity, disease progression, and the clinical conditions
after surgery (3).
The “status of PC” information can contribute to better
planning, recovery, and improvement of life expectancy
of patients. Typically, after surgery, patients have a low
level of physical activity as recorded in the six-minute walk
test (6MWT) and the six-minute step test (6MST) (1). In a
study, these values were lower than those predicted for
the normal Brazilian adult population (1). This may be ex-
plained by the occurrence of chronic muscular fatigue af-
ter surgery causing a decline in daily activity. However, no
study focused on the long-term examination of physical
activity levels or the correlation between physical activity
and LQ a long time after transplantation.
Given the need for understanding PC and LQ in early
stages after LxT and because the long-term effects of LxT
are unknown in patients, this study aimed to verify the im-
provement of PC and LQ one to six months after LxT and
assess the correlation between physical activity and LQ of
patients.
2. Methods
It was a pilot observational longitudinal study ap-
proved by the Ethics and Research Committee (922/2009).
The PC and the LQ were evaluated using 6MST and SF-36, re-
spectively, one month, three months, and six months after
LxT.
2.1. Subjects
The inclusion criteria included patients adults, after
one month of hospitalization for transplantation or major
lung surgery and no major heart problems. The exclusion
criteria included patients with the sequel of motor func-
tion or cognitive issues, as they could not endure the phys-
ical tests, the signs of organ rejection, and hemodynamic
instability.
2.2. Data Collection andMeasurements
Information about clinical and surgical characteristics
included respiratory muscle strength (Muscle Inspiratory
Pressure (MIP) and Muscle Expiratory Pressure (MEP) (4)
and spirometry (the expected percentage of Forced Vital
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Capacity (FVC) and forced expiratory volume in the first
second (VEF1) (5).
Six-min step test (2): The numbers of steps were
recorded along with the physiological parameters. The
values obtained in three evaluations were compared with
each other and with expected (predictive) values (6).
2.3. Statistical Analysis
Shapiro-Wilk test was used for checking the normal-
ity of the data. The comparison of groups was done us-
ing the Tukey test for data with normal distribution and
Kruskal-Wallis test for data with non-normal distribution.
Paired Wilcox test was used to determine which of the
three stages of the evaluation was statistically different
from others. Student t-test was used to compare the ex-
pected values and the actual number of steps in 6MST (with
normal distribution). To verify the correlation between the
number of steps and LQ, we employed a simple linear re-
gression. SPSS V. 21.0 was used and the alpha value was set
at 0.05.
3. Results
We used specific inclusion criteria to restrict the num-
ber of participants and seek complex cases for the study.
Initially, 30 participants were selected of whom 12 were ex-
cluded as they did not meet the inclusion criteria. The data
of 18 patients were collected in the first stage of the evalu-
ation. In the second stage, five patients developed compli-
cations of organ transplantation (three died).
The majority of the sample was male (72%) with an av-
erage age of 54.50 and a MELD score of 24.50 before LxT.
The most common cause of the liver disease was hepatitis
C virus (61%) infection, followed by alcohol consumption
(33.3%). The median waiting time for transplantation was
six months. Piggy Back technique and Orthotopic LxT were
used.
Pulmonary functional test results showed the VEF1 of
75.1 ± 22.56% and the CVF of 74.7 ± 20.22%; the respiratory
muscle strength was 81.7 ± 35.06 cm H2O in MIP and 100
cm H2O in MEP.
Supplementary file appendix 1 shows the results of
PC as evaluated by 6MST (number of steps) in the three
stages of evaluation. We found a statistically significant dif-
ference between the stages (P = 0.00007), specifically be-
tween the first and third months after surgery (P = 0.01).
The average numbers of expected steps were 141 steps for
each patient. The significance is highlighted in Supple-
mentary file appendix 2 for all the stages of evaluation.
Supplementary file appendix 3 shows the results of LQ.
The results were statistically significant between the three
stages of evaluation for FC, mainly between the first and
third stages (P = 0.0001) and between the second and third
stages (P = 0.004). For the LPA, a statistically significant dif-
ference was observed between the first and second stages
(P = 0.035) and between the first and third stages (P = 0.07).
It was significant in the domain of vitality when compar-
ing the first and third stages (P = 0.005), the second and
third stages (P = 0.020), and finally the first and third stages
for EA (P = 0.018). We could not observe any correlation be-
tween 6MST and quality in any evaluation stage (P < 0.05).
4. Discussion
In this study, we observed that the PC of patients is sig-
nificantly related to the number of steps from a period of
one to six months after LxT. When we compared the ac-
tual values with the predictive values, we observed signifi-
cant differences between all stages of evaluation. This im-
plies that patients had significant differences in PC even six
months after surgery, and PC presented continuous dam-
age in this period.
Our results are in alignment with the results by Mag-
alhaes et al. (1), who measured PC in patients one month
after LxT using TD6 and 6MST. Their results indicated that
patients had impaired physical function with low expected
(predictive) values. VanWagner et al. (7) studied PC using
6MWT over a long period (one, three, six, and 12 months)
after surgery, and found that patients showed a gradual im-
provement in each stage of evaluation, but the values were
lower than predictive values at all evaluation times. This
may be due to some factors. The first factor is the immuno-
suppression medication used over a long period that may
have led to the impairment of the musculoskeletal, cardio-
vascular, and respiratory systems and metabolic disorders
(7). The second factor is that patients with end-stage liver
disease present muscle mass loss that may affect periph-
eral and respiratory muscle, leading to chronic fatigue and
protein wasting possibly remaining for up to one year after
surgery (1).
In our study, we observed that a month after LxT, the
quality of life was low in all aspects measured. However,
after long periods (six months), the FC, LPA, vitality, and EA
scores improved with significant differences between the
three evaluation stages.
There are limited studies of the quality of life after
LxT, with controversial results. Bownik et al. (8) showed
that patients were poor on all the domains of SF-36 one
month after surgery, but they improved gradually during
six months. Some authors challenged this assertion. No-
tably, Burra and Germani (9) concluded that all aspects
of SF-36, except for physical aspects, improved six months
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post-LxT. This may be explained by several factors that in-
fluence LQ after LxT, including the etiology of liver dis-
ease, social and demographic factors, immunosuppres-
sion therapy, waiting time for LxT, sexual activity, compli-
cations of organ rejection, infection, and biliary events (3).
No significant differences were observed in this study
when LQ was correlated to the measurements from SF-36
and PC, and measurements from 6MST at six months after
LxT in this study. The LQ recovered in most cases within six
months after LxT but the PC was low in many cases. Limited
research is available to decipher the reasons. We believe
that LQ is a subjective measure that may be influenced by
several physiological factors while PC is a direct measure.
4.1. Clinical Implication, Strengths and Limitations of the Study
Compared to previous studies, there are two main
strengths in the current study. First, this is the first study
of evaluating the improvement of PC and LQ in patients af-
ter LxT in a long time (six months). Second, there are no
previous studies on the correlation between PC and LQ. The
main limitation of this study was the small sample size al-
though it can be justified by highlighting the specificity
of inclusion criteria, the characteristics of patients in the
study, and the long time of monitoring and follow-up.
5. Conclusions
Patients subjected to LxT may experience declined PC
within a month after LxT. This condition tends to improve
in six months. However, it does not return to predictive val-
ues. A month after surgery, the LQ is significantly affected,
particularly in the main domains of SF-36. The scores ap-
pear to return to the ideal state within six months after
surgery. The improvement of these capacities after LxT
could be explained by some associated factors such as so-
cial and demographic variables, pre-operative situations
(muscle mass loss, waiting time for LxT, and etiology of
liver disease) and post-operative situation (immunosup-
pression therapy, complications of organ rejection and in-
fection).
Supplementary Material
Supplementary material(s) is available here [To read
supplementary materials, please refer to the journal web-
site and open PDF/HTML].
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